BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26512432)

  • 1. Readmissions related to antihypertensive medications used in chronic hemodialysis.
    Honkonen MN; McNeill P; Jasensky A; Erstad BL
    Ren Fail; 2016; 38(1):40-5. PubMed ID: 26512432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden and correlates of readmissions related to pulmonary edema in US hemodialysis patients: a cohort study.
    Plantinga LC; King LM; Masud T; Shafi T; Burkart JM; Lea JP; Jaar BG
    Nephrol Dial Transplant; 2018 Jul; 33(7):1215-1223. PubMed ID: 29294094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-hospitalization dialysis facility processes of care and hospital readmissions among hemodialysis patients: a retrospective cohort study.
    Plantinga LC; Masud T; Lea JP; Burkart JM; O'Donnell CM; Jaar BG
    BMC Nephrol; 2018 Jul; 19(1):186. PubMed ID: 30064380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive Hemodialysis, Blood Pressure, and Antihypertensive Medication Use.
    Bakris GL; Burkart JM; Weinhandl ED; McCullough PA; Kraus MA
    Am J Kidney Dis; 2016 Nov; 68(5S1):S15-S23. PubMed ID: 27772639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload.
    Banerjee D; Ma JZ; Collins AJ; Herzog CA
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1186-90. PubMed ID: 17942779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Control of arterial hypertension by means of a regimen of hemodialysis on alternate days (HDAA or EODD: "Every Other Day Dialysis") versus 2 conventional regiments of 4 and 5 hours per session 3 times a week with 72 hours without sessions during the weekends].
    Lozano A; Benavides B; Quirós P; Jiménez-Moreno J; Figueroa E; Fernández-Marchena D; García-Pérez MA; Fernández-Ruiz E
    Nefrologia; 2006; 26(6):695-702. PubMed ID: 17227247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodialysis-associated hypertension: pathophysiology and therapy.
    Hörl MP; Hörl WH
    Am J Kidney Dis; 2002 Feb; 39(2):227-44. PubMed ID: 11840363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of beta-blocker use on volume status in hemodialysis patients.
    Bi SH; Linke L; Wu J; Cheng LT; Wang T; Ahmad S
    Blood Purif; 2012; 33(4):311-6. PubMed ID: 22699805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of antihypertensive drugs in hypertensive patients on renal replacement therapy (RRT).
    Zazgornik J; Biesenbach G; Forstenlehner M; Stummvoll K
    Clin Nephrol; 1997 Dec; 48(6):337-40. PubMed ID: 9438090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.
    Karunaratne K; Stevens P; Irving J; Hobbs H; Kilbride H; Kingston R; Farmer C
    Nephrol Dial Transplant; 2013 Aug; 28(8):2107-16. PubMed ID: 23658247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR.
    Kojima M; Taniguchi M; Sato K; Ueda R; Dohi Y
    Nephron Clin Pract; 2004; 97(2):c49-53. PubMed ID: 15218330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of captopril-bound Fe by end-stage renal failure patients during hemodialysis.
    Averbukh Z; Berman S; Kishinevsky E; Feldman L; Cohn M; Rapoport M; Galperin E; Dishi V; Weissgarten J
    J Nephrol; 2004; 17(1):101-6. PubMed ID: 15151265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.
    Zheng S; Nath V; Coyne DW
    Am J Nephrol; 2007; 27(5):522-9. PubMed ID: 17700014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapy for hypertension in hemodialysis patients.
    Hörl MP; Tepel M
    Minerva Med; 2005 Aug; 96(4):277-85. PubMed ID: 16179894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital treatment for fluid overload in the Medicare hemodialysis population.
    Arneson TJ; Liu J; Qiu Y; Gilbertson DT; Foley RN; Collins AJ
    Clin J Am Soc Nephrol; 2010 Jun; 5(6):1054-63. PubMed ID: 20430944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Age and arterial hypertension in hemodialysis patients].
    Marinac D; Josipović J; Pavlović D
    Acta Med Croatica; 2012 Jul; 66(3):165-71. PubMed ID: 23441530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension in hemodialysis patients in Andalucia].
    García Cortés MJ; Ceballos M;
    Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure recordings during hemodialysis access interventions: implications for acute management.
    Asif A; Castro H; Waheed AA; Kumar V; Haqqie SS; Siskin G; Mathew RO; Mason D; Vachharajani T; Nayer A; Merrill D; Akmal MU; Salman L
    Semin Dial; 2013; 26(4):E30-2. PubMed ID: 23551213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks associated with continuation of potentially inappropriate antihypertensive medications in older adults receiving hemodialysis.
    Hall RK; Morton S; Wilson J; Ephraim PL; Boulware LE; St Peter WL; Colón-Emeric C; Pendergast J; Scialla JJ
    BMC Nephrol; 2021 Jun; 22(1):232. PubMed ID: 34147085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluid overload is associated with use of a higher number of antihypertensive drugs in hemodialysis patients.
    Morais JG; Pecoits-Filho R; Canziani MEF; Poli-de-Figueiredo CE; Cuvello Neto AL; Barra AB; Calice-Silva V; Raimann JG; Nerbass FB
    Hemodial Int; 2020 Jul; 24(3):397-405. PubMed ID: 32157798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.